Burnet Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Burnet Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9374
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Burnet Institute is a non-profit and independent organization that improves health of poor and vulnerable communities through research, education and public health. The institute offers solutions to major health issues through development and discovery of novel vaccines, diagnostic tests and implementation of public health practices. It caters to various infectious diseases such as hepatitis viruses, malaria, influenza, HIV and AIDS, and others. Burnet Institute also concentrates on immunity, vaccines and immunization; maternal and child health; alcohol, other drugs and harm reduction; sexual and reproductive health and young people’s health. It also offers educational programs such as honors, masters and Ph.D. degrees. Burnet Institute is headquartered in Melbourne, Victoria, Australia.

Burnet Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Burnet Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Burnet Institute, Medical Devices Deals, 2012 to YTD 2018 9
Burnet Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Burnet Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
GeoVax Labs Enters into Research Agreement with Burnet Institute 11
Artes Biotechnology Enters into Agreement with Burnet Institute 12
Artes Biotech Enters into Co-Development Agreement with Burnet Institute 13
Burnet Institute – Key Employees 14
Burnet Institute – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Jul 07, 2017: Burnet Institute: The case for new hepatitis C treatments 17
Jun 01, 2017: Funding for new PNG TB project 18
May 19, 2017: MRFF funding for clinical trials welcomed 19
May 02, 2017: Burnet welcomes vital funding boost by Victorian Government 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Burnet Institute, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Burnet Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Burnet Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Burnet Institute, Medical Devices Deals, 2012 to YTD 2018 9
Burnet Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GeoVax Labs Enters into Research Agreement with Burnet Institute 11
Artes Biotechnology Enters into Agreement with Burnet Institute 12
Artes Biotech Enters into Co-Development Agreement with Burnet Institute 13
Burnet Institute, Key Employees 14
Burnet Institute, Subsidiaries 16

List of Figures
Burnet Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Burnet Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Burnet Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Burnet Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Burnet Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NuStar Energy LP (NS):石油・ガス:M&Aディール及び事業提携情報
    Summary NuStar Energy LP (NuStar Energy) is a midstream oil and gas company. It carries out the transportation, terminalling, storage and marketing of petroleum products, and anhydrous ammonia. The company owns and operates pipelines, terminal and storage facilities that store and distribute crude o …
  • Pennon Group Plc (PNN):企業の財務・戦略的SWOT分析
    Pennon Group Plc (PNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Quest Diagnostics Inc (DGX)-医療機器分野:企業M&A・提携分析
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • Cedars-Sinai Medical Center:企業のM&A・事業提携・投資動向
    Cedars-Sinai Medical Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cedars-Sinai Medical Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Spineway SAS (ALSPW):企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Scottish and Southern Energy plc:企業の戦略・SWOT・財務分析
    Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report Summary Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Murphy USA Inc:企業の戦略・SWOT・財務分析
    Murphy USA Inc - Strategy, SWOT and Corporate Finance Report Summary Murphy USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • EnCana Corporation (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • ShaMaran Petroleum Corp (SNM):石油・ガス:M&Aディール及び事業提携情報
    Summary ShaMaran Petroleum Corp (ShaMaran Petroleum), formerly Bayou Bend Petroleum Ltd is an independent oil and gas exploration and development company. The corporation explores, produces, and develops oil and gas assets. It holds interests and operates Atrush petroleum property located in Kurdist …
  • Tishman Realty & Construction Co., Inc.:企業の戦略・SWOT・財務情報
    Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Wintershall Holding GmbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Wintershall Holding GmbH (Wintershall) explores for production of oil and natural gas. It operates as a subsidiary of BASF Group. The company holds expertise in conducting geological studies, geophysical measurements, seismic surveys, reservoir modeling, field development, onshore and offsho …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Sv. Sv. Konstantin I Elena Holding Ad:企業の戦略・SWOT・財務分析
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • The Jackson Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary The Jackson Laboratory (JAX) is a biomedical research center that offers clinical genomic solutions. The center provides breeding and rederivation services. It offers cryopreservation and recovery services such as sperm cryopreservation, on-site sperm cryopreservation, embryo cryopreservatio …
  • Promore Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Promore Pharma AB (Promore), formerly Pergamum AB is a biopharmaceutical company that develops peptide-based product candidates for local and topical treatment of infections and wounds. The company’s pipeline products include LL-37 and PXL01 therapeutic peptides. Its PXL01 is used for the pr …
  • Bombardier Inc:企業の戦略・SWOT・財務情報
    Bombardier Inc - Strategy, SWOT and Corporate Finance Report Summary Bombardier Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tanzania Electric Supply Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Tanzania Electric Supply Co Ltd (TANESCO), formerly Tanganyika Electric Supply Co Ltd, is a government-owned integrated power company. The company’s operations are regulated by the Ministry of Energy and Minerals. It generates, transmits, distributes and supplies electricity. TANESCO generat …
  • AnaMar AB:医療機器:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆